Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report

Medicine (Baltimore). 2017 Jun;96(23):e7098. doi: 10.1097/MD.0000000000007098.

Abstract

Introduction: We herein present 2 cases involving the combination of rocuronium and sugammadex in patients with motor neuron disease. The patients were a 54-year-old man with progressive muscular atrophy who underwent removal of internal fixators in the arm and leg, and a 66-year-old woman with amyotrophic lateral sclerosis who underwent skin grafting in the left lower leg. General anesthesia was induced with propofol, rocuronium, and remifentanil and maintained with desflurane and remifentanil. At the end of the surgical procedure, we administered sugammadex. Three or 4 minutes after administration of sugammadex, the patients began to breathe spontaneously and were extubated without complications.

Conclusion: Sugammadex can be used successfully to reverse neuromuscular blockade in patients with motor neuron disease.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / surgery*
  • Androstanols / therapeutic use
  • Anesthesia Recovery Period
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscular Atrophy, Spinal / drug therapy*
  • Muscular Atrophy, Spinal / surgery*
  • Neuromuscular Agents / therapeutic use*
  • Neuromuscular Blockade
  • Rocuronium
  • Sugammadex
  • gamma-Cyclodextrins / therapeutic use*

Substances

  • Androstanols
  • Neuromuscular Agents
  • gamma-Cyclodextrins
  • Sugammadex
  • Rocuronium